TRACON Pharmaceutical (TCON) Misses Q1 EPS by 127c

TRACON Pharmaceutical (NASDAQ: TCON) reported Q1 EPS of ($1.33), $1.27 worse than the analyst estimate of ($0.06). Revenue for the quarter came in at $100 thousand.

For earnings history and earnings-related data on TRACON Pharmaceutical (TCON) click here.

You May Also Be Interested In

• Tesla plans 'flying' Roadster stunt at SpaceX Texas site as early as August
• Boost Run, Inc. (BRUN) Reports Q2 Revenue of $31.1M
• Movano (MOVE) Misses Q2 EPS by 195c